{
    "query": "Sarah Miller, a 43-year-old female with a history of rheumatoid arthritis, type 2 diabetes mellitus, essential hypertension, and metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), developed severe drug-induced liver injury (DILI) approximately 6 weeks after starting methotrexate 7.5 mg weekly for RA. Initial presentation included ALT 185 U/L which progressed to ALT 490 U/L and bilirubin 110 μmol/L, with subsequent peak bilirubin of 190 μmol/L, accompanied by jaundice. Methotrexate was discontinued and N-acetylcysteine (NAC) administered. RUCAM score was 9, indicating highly probable DILI. What is the DILI diagnosis according to EASL guidelines?\n",
    "metadata": {
        "source": "voice"
    }
}